HR-88: A RESOLUTION encouraging the Kentucky Department for Public Health, in conjunction with the Kentucky Office of Drug Control Policy, to issue a public statement to increase awareness in the Commonwealth on the potential harm of consuming 7-hydroxymitragynine products.
Sponsored by: Rep. Robert Duvall
Introduced In House on 03/13/2025
You have voted HR-88: A RESOLUTION encouraging the Kentucky Department for Public Health, in conjunction with the Kentucky Office of Drug Control Policy, to issue a public statement to increase awareness in the Commonwealth on the potential harm of consuming 7-hydroxymitragynine products..
AN ACT relating to reproductive health services. [HB-793]
Create a new section of KRS Chapter 211 to define terms; provide rights related to access to contraception; create private right of action; create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for contraception; amend KRS 304.17A-099 to exclude contraception from cost defrayal requirements; require health benefit plans to provide coverage for long-acting reversible contraception administered during a postpartum hospital stay; amend KRS 164.2871, 205.522, 205.6485, and 18A.225 to require self-insured
(continued...)
HB-793: AN ACT relating to reproductive health services.
Sponsored by: Rep. Sarah Stalker
To Banking & Insurance (h) on 02/27/2025
AN ACT relating to regulated beverages. [HB-734]
Amend KRS 241.010 to define "cannabinoid" and "cannabis-infused beverage"; create a new section of KRS Chapter 243 to indicate that the Department for Public Health regulates the manufacture, distribution, and retail sale of cannabis-infused beverages containing cannabinoids; make technical corrections; amend KRS 217.039, 243.034, and 243.0341 to conform.
HB-734: AN ACT relating to regulated beverages.
Sponsored by: Rep. Matthew Koch
Taken From Licensing, Occupations, & Administrative Regulations (h) on 03/04/2025
AN ACT relating to informed consent for medical examinations. [HB-795]
Create a new section of KRS Chapter 216 to define terms; prohibit a health care provider from performing a pelvic, rectal, or prostate examination without the informed consent of the patient or the person authorized to make health care decisions for the patient; provide for certain exceptions including a court order; require violators to be subject to discipline by the appropriate professional licensing board or accrediting agency.
HB-795: AN ACT relating to informed consent for medical examinations.
Sponsored by: Rep. Sarah Stalker
To Health Services (h) on 02/27/2025
AN ACT relating to buprenorphine products. [HB-788]
Create a new section of KRS Chapter 311 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed physician to meet the treatment needs of a patient; require the Kentucky Board of Medical Licensure to promulgate administrative regulations to implement the requirement; create a new section of KRS Chapter 314 to require that a dosage regimen for Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone prescribed by a licensed advanced practice registered nurse meet the
(continued...)
HB-788: AN ACT relating to buprenorphine products.
Sponsored by: Rep. Kimberly Moser
Taken From Health Services (h) on 03/05/2025
AN ACT relating to public health and safety. [HB-745]
Amend KRS 214.450 to define "autologous donation" and "directed donation"; amend KRS 214.452 to require blood establishments to test for spike proteins, antibodies to the nucleocapsid protein on the SARS-CoV-2 virus, and synthetic mRNA; provide that a person shall not be compelled to donate blood; require blood establishments to inform donors of the potential uses for donations; require blood to be sold to hospitals before any other entity; prohibit blood from sale for pharmaceutical production if there is a hospital blood shortage; amend KRS 214.454
(continued...)
HB-745: AN ACT relating to public health and safety.
Sponsored by: Rep. Josh Calloway
To Health Services (h) on 02/27/2025
AN ACT relating to liability shield products and declaring an emergency. [HB-648]
Create a new section of KRS Chapter 217 to define terms; require a manufacturer of a liability shield product to subject the product to a placebo-controlled study before it is manufactured, marketed, distributed, or administered in Kentucky; establish requirements for the placebo-controlled study; require the Cabinet for Health and Family Services to monitor and track adverse outcomes of liability shield products; require manufacturers of liability shield products to submit documentation to the cabinet of the placebo-controlled study and results
(continued...)
HB-648: AN ACT relating to liability shield products and declaring an emergency.
Sponsored by: Rep. Savannah Maddox
To Health Services (h) on 02/26/2025
AN ACT relating to the 340B Drug Pricing Program. [HB-685]
Create a new section of KRS Chapter 216 to define terms; require nonprofit hospitals to submit a 340B Drug Pricing Program report to the Cabinet for Health and Family Services by July 1, 2026, and annually thereafter; direct the Personnel Cabinet to submit a report to the Legislative Research Commission on the impact of the 340B Drug Pricing Program on the Kentucky Employee Health Plan no later than December 1, 2025; require the Cabinet for Health and Family Services to submit a report to the Legislative Research Commission on the impact of the
(continued...)
HB-685: AN ACT relating to the 340B Drug Pricing Program.
Sponsored by: Rep. Kimberly Moser
To Health Services (h) on 02/26/2025
AN ACT relating to blood donation. [HB-601]
Amend KRS 214.452 to add receipt of a COVID -19 vaccine to the blood donor risk factor statement collected by a blood establishment; amend KRS 214.458 to add donor receipt of a COVID-19 vaccine to the donor identification information affixed to a unit of donated blood; add that except in an emergency, a patient be informed if the donor of the blood to be transfused had received a COVID-19 vaccine.
HB-601: AN ACT relating to blood donation.
Sponsored by: Rep. Ryan Dotson
To Health Services (h) on 02/26/2025
AN ACT relating to coverage for the treatment of postpartum mood disorders. [HB-683]
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for FDA-approved prescription drugs for the treatment of postpartum mood disorders; allow the suspension of the coverage requirement for FDA-approved prescription drugs for the treatment of postpartum mood disorders under qualified health plans if cost defrayment required by the state; amend KRS 205.522, 205.6485, 18A.225, and 164.2871 to require Medicaid, Kentucky Children's Health Insurance Program, the state health employee health plan,
(continued...)
HB-683: AN ACT relating to coverage for the treatment of postpartum mood disorders.
Sponsored by: Rep. Chad Aull
To Banking & Insurance (h) on 02/26/2025
AN ACT relating to ivermectin for human use. [HB-668]
Create a new section of KRS Chapter 218A to permit the sale or purchase of ivermectin that's been approved for human use without a prescription from a practitioner.
HB-668: AN ACT relating to ivermectin for human use.
Sponsored by: Rep. Thomas Huff
To Health Services (h) on 02/26/2025
AN ACT relating to medical products. [HB-646]
Create a new section of KRS Chapter 216 to define "medical product"; prohibit any a public or government entity or any agency or division thereof, from requiring an individual to take, receive, or disclose whether a medical product has been taken or received, unless the manufacturer of the product is liable for any death or injury caused by the product.
HB-646: AN ACT relating to medical products.
Sponsored by: Rep. Savannah Maddox
To Health Services (h) on 02/26/2025
AN ACT relating to Ibogaine research in the Commonwealth. [SB-240]
Create new sections of KRS 218A to define terms; establish the intent of the General Assembly that ibogaine is worthy of clinical research, trials, and studies as a potential viable therapeutic treatment of opioid dependence and any other co-occurring mental health disorders; establish a trust and agency account entitled the ibogaine research fund; establish a process for private entities to apply to the Department of Agriculture for access to funds in the Ibogaine Research Fund.
SB-240: AN ACT relating to Ibogaine research in the Commonwealth.
Sponsored by: Sen. Donald Douglas
To Health Services (s) on 02/20/2025
AN ACT relating to health care. [HB-688]
Amend KRS 314.041, relating to registered nurse licensure, and KRS 314.051, relating to licensed practical nurse licensure, to permit rather than require the board to issue credentials; amend KRS 314.042 to require physicians collaborating with an advanced practice registered nurse to have an active and unrestricted license in Kentucky; amend KRS 314.109 to reduce the time from 90 to 30 days for a person under the jurisdiction of the board to notify the board of a conviction of certain misdemeanors or felonies; amend KRS 209.032, relating to employees
(continued...)
HB-688: AN ACT relating to health care.
Sponsored by: Rep. Kimberly Moser
2nd Reading, To Rules on 03/12/2025
AN ACT relating to liability for injury or damage caused by the underage consumption of intoxicating substances. [SB-182]
Create a new section of KRS Chapter 411 to allow a person injured due to the negligence of an intoxicated minor to bring a civil action against a person who knew or should have known that the minor consumed alcohol or a controlled substance in the person's home or on property under the person's control, and against any person, other than the minor's parent, who provided the alcohol or controlled substance to the minor.
SB-182: AN ACT relating to liability for injury or damage caused by the underage consumption of intoxicating substances.
Sponsored by: Sen. Gerald Neal
To Judiciary (s) on 02/19/2025
AN ACT relating to opioid antagonists. [HB-547]
Amend KRS 217.186 to require each public postsecondary educational institution to provide access to opioid antagonists on campus; permit access to be provided by emergency opioid antagonist cabinets; permit application for funds from the opioid abatement trust fund and other available sources to coordinate, maintain, and supply the opioid antagonists; amend KRS 15.291 to add providing access to opioid antagonists on the campuses of public postsecondary educational institutions to the list of projects that may be provided with funding from the opioid
(continued...)
HB-547: AN ACT relating to opioid antagonists.
Sponsored by: Rep. Chad Aull
To Health Services (h) on 02/25/2025